An attorney has asked jurors to hold a J&J subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.
The first two trials of more than 2,400 lawsuits nationwide accuse the drug, which was made by Pfizer, of causing the patient to commit suicide.
The FDA asked the Mountain View, Calif.-based company to address "observations from a recent facility inspection of a third party manufacturer."
Eye-health company Bausch & Lomb plans to buy eye-drug maker Ista Pharmaceuticals Inc. for about $500 million in cash.
The Warsaw, Ind.-based medical device maker won't be prosecuted by the Justice Department if it institutes strict internal controls to prevent bribery.
Irish drug and medical device maker Covidien PLC said it is buying ventilator maker Newport Medical Instruments Inc. for about $108 million.
Members of Congress say these groups are playing a "shell game" — to make money by taking advantage of the drug shortage crisis.
SiO2 Medical Products is investing $90 million in the Alabama plant, which will make products for the biological drugs industry.
Instead of manufacturing drugs using a conventional batch-based system, MIT and Novartis envisioned a continuous manufacturing process, all done in one location, which would cut down on time and cost.
Irish medical device and drug maker agreed to buy Israel-based superDimension Ltd. for about $300 million initially plus possible future payments.
William Weldon, who will step down next month after a decade as CEO, oversaw about 30 product recalls since 2009, which cost about $1 billion.
Illumina's board unanimously turned down Roche's hostile takeover offer last month, saying it was "grossly inadequate."
Drugmakers tout the nerve growth factor inhibitors as a breakthrough for treating chronic pain, but those in previous studies reported bone decay and joint failure.
British experts at the world's biggest artificial joint registry said metal versions have to be fixed or replaced more often than other implants.
Japanese chemical manufacturer has agreed to buy Zoll Medical Corp, which makes defibrillators and other critical care medical devices, for about $2.2 billion.
Medical equipment maker Teleflex Inc. said Monday that it has named Thomas Powell as chief financial officer, succeeding Richard Meier.
Medical device maker said it will pay at least $150 million to acquire Cameron Health Inc., maker of a minimally-invasive heart defibrillator.
Driving the move is a wave of computer technology, including touch-screen kiosks found in pharmacies, designed to help patients self-diagnose common diseases.
Community Catalyst alleges increasingly common couponing programs appear to save patients money but violate federal bribery laws.
Cheng Yi Liang pleaded guilty to using a confidential drug database to buy stock in various companies, which earned him nearly $3.8 million.
The FDA is requiring additional study data on the compound, which combines Lipitor, the top-selling drug of all time, with Merck's cholesterol medicine Zetia.
Medical firm and former execs convicted of running unauthorized clinical tests of bone cement are blamed for contributing to the deaths of two elderly women.
The South Korean electronics giant is branching out and is developing new drugs in cooperation with two American biotech firms.
Counterfeit versions of the popular cancer drug Avastin are completely ineffective, but would not likely have a dramatic effect on survival odds.
The company says its earnings picture was "mixed," and gave a cautious outlook for 2012 given "an economic situation marked by uncertainty."